Question 1

What is SCT?

Accepted Answer

SCT is SuperCells Token, the platform payment and governance token used in the SuperCells ecosystem. Project materials position it as the governance token of the SuperCells stem-cell metaverse; it is not the platform service itself, nor is it a promise of any medical service or outcome. SCT should therefore be understood by distinguishing three things: the token may be used in payment-discount scenarios set by the platform; its governance positioning relates to ecosystem decisions; and actual service content, eligibility conditions, and whether discounts are available remain determined by the arrangements the platform provides at the relevant time.

Question 2

What are SCT's main uses?

Accepted Answer

SCT's main uses are platform-service payment discounts and ecosystem governance. The former means that, where the platform sets SCT payment or discount rules for a service, users may use the token under those rules; it does not mean holding the token alone grants access to a service. The latter means SCT is positioned as the governance token of the SuperCells ecosystem. The project's public materials used for this question do not specify voting thresholds, weights, or execution processes for each governance matter, so holding SCT cannot be further described as necessarily conferring any particular voting right.

Question 3

What does SCT's role as a governance token mean?

Accepted Answer

SCT's role as a “governance token” means it serves SuperCells ecosystem governance arrangements; it is not a credential that automatically redeems platform services. Its governance positioning indicates that the token has a role in the ecosystem's decision-making framework, while payment discounts are a separate service-use function. The two are not interchangeable: even if the platform offers SCT payment discounts, token holders do not thereby automatically receive a particular service, service priority, or medical outcome; likewise, governance positioning itself is not a guarantee by the platform of token value.

Question 4

How can SCT supply change?

Accepted Answer

SCT supply is not described in the sources for this question as a completely unchanged fixed quantity. The white paper states that issuance management may adjust the minting pace according to market demand and ecosystem development, and includes a burn mechanism. Minting is the process of adding SCT: a faster or slower minting pace changes the rate at which new tokens enter supply. Burning removes tokens from available supply; all else equal, it moves in the opposite direction from minting. Together, these mechanisms affect the path of supply changes, but the white paper summary does not confirm a fixed total supply, the size of each mint, burn triggers, or current circulating supply, so specific amounts cannot be inferred from it.

Question 5

What should I note when using or trading SCT?

Accepted Answer

Before using or trading SCT, first verify that the asset is SuperCells Token and that its network, receiving address, and channel being used are consistent. If the network or contract identifier differs, an asset may not be the same even if its name or symbol is identical. Next, assess token utility separately from service entitlements. SCT may be associated with platform payment discounts, but eligible services and conditions may change; token price and tradable supply may also change with market trading and minting and burning arrangements. Holding or paying with the token does not guarantee medical-service outcomes, fixed value, or investment returns.

Question 6

Does holding SCT guarantee access to platform services?

Accepted Answer

No. SCT is associated with payment discounts for SuperCells platform services, but holding the token itself does not mean a user has purchased, booked, or been approved to use a particular platform service. Whether a service may be used depends on whether the platform offers it at that time and whether the user meets its payment, eligibility, and other applicable conditions. This distinction also means that SCT's governance positioning or supply-management mechanisms do not automatically become service eligibility, service outcomes, or fixed economic returns. Users need to confirm platform rules for the particular service instead of deciding based only on token-holding status.

Question 7

What is the difference between platform discounts and SCT's market price?

Accepted Answer

SCT payment discounts and its market price operate at different levels. Payment discounts depend on whether the platform establishes SCT-use rules for a particular service; market price is affected by factors such as buy and sell demand in trading, tradable supply, and market expectations. Supply management may alter the supply path through additional minting or burning, but it is not a commitment to a price outcome. Only if other conditions are unchanged may supply changes affect trading conditions; whether platform services are actually available, how discount rules are set, and whether market participants are willing to trade can all produce different outcomes.

Question 8

How should SCT minting, circulation, and burning be understood?

Accepted Answer

Minting, allocation, circulation, and burning are not the same concepts. Minting creates additional tokens; allocation means created tokens are assigned or distributed under some arrangement; circulation describes the portion actually available for market trading; and burning removes tokens from available supply. The white paper confirms that SCT issuance management includes adjustments to minting pace and a burn mechanism, but the materials used for this question do not confirm current circulating supply, a fixed total supply, or a specific allocation and unlock schedule. Therefore, a particular mint or burn cannot be equated directly with all tokens being in circulation, nor can a definite price effect be inferred from it.

SuperCells Token (SCT) Price